These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8253459)

  • 21. Presence of malignant mesothelial cells in the sputum.
    Choi YH; Park KY; Ryoo BY; Na II; Yang SH; Koh JS; Kim CH; Lee JC
    Intern Med; 2008; 47(1):57-60. PubMed ID: 18176007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.
    Wirth PR; Legier J; Wright GL
    Cancer; 1991 Feb; 67(3):655-62. PubMed ID: 1702354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appearance of mesothelioma cells in sputum. A case report.
    Nakajima M; Manabe T; Yagi S
    Acta Cytol; 1992; 36(5):731-6. PubMed ID: 1523933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma.
    Saito R; Kasajima A; Taniuchi S; Fujishima F; Ishida K; Nakamura Y; Yamanda S; Takahashi T; Hitomi H; Murakami K; Watanabe M; Sasano H
    Pathol Int; 2012 Oct; 62(10):709-15. PubMed ID: 23005599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical comparison of diffuse malignant mesothelioma of the pleura and pseudomesotheliomatous carcinoma of the lung for each case].
    Yuasa H; Tomoyasu M
    Kyobu Geka; 1999 Sep; 52(10):836-9. PubMed ID: 10478545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma.
    Nakano T; Chahinian AP; Shinjo M; Tonomura A; Miyake M; Togawa N; Ninomiya K; Higashino K
    Br J Cancer; 1998 Mar; 77(6):907-12. PubMed ID: 9528833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case of triple malignancies (gastric cancer, lung cancer and malignant pleural mesothelioma) after asbestos exposure].
    Kishimoto T
    Nihon Kokyuki Gakkai Zasshi; 2003 Apr; 41(4):304-9. PubMed ID: 12795187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunopathology of malignant mesothelioma.
    Sheibani K; Stroup RM
    Pathology (Phila); 1996; 4(1):191-212. PubMed ID: 8953621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
    Sheibani K; Battifora H; Burke JS
    Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucin-negative pseudomesotheliomatous adenocarcinoma of the lung: report of three cases.
    Oka K; Otani S; Yoshimura T; Hashimoto T; Tobita T; Koyamatsu S; Hakozaki H; Yatabe Y
    Acta Oncol; 1999; 38(8):1119-21. PubMed ID: 10665774
    [No Abstract]   [Full Text] [Related]  

  • 32. Extensive pulmonary metastases in malignant pleural mesothelioma. A rare clinical and radiographic presentation.
    Ohishi N; Oka T; Fukuhara T; Yotsumoto H; Yazaki Y
    Chest; 1996 Jul; 110(1):296-8. PubMed ID: 8681649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of closed-needle biopsy in the diagnosis of malignant mesothelioma of the pleura.
    Roggli VL
    Chest; 1994 Jan; 105(1):321-2. PubMed ID: 8275772
    [No Abstract]   [Full Text] [Related]  

  • 34. Malignant mesothelioma invading the spinal canal.
    Cooper D
    Postgrad Med J; 1974 Nov; 50(589):718-23. PubMed ID: 4377581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cytodiagnosis of pleural mesotheliomas].
    Castelain G; Castelain C; Pretet S; Kreis B
    Presse Med (1893); 1969 Feb; 77(6):197-9. PubMed ID: 4182143
    [No Abstract]   [Full Text] [Related]  

  • 36. [Follow- up of a pleural malignant mesothelioma].
    Vanwijck R; Verschakelen JA; Baert AL
    J Belge Radiol; 1992 Oct; 75(5):389-91. PubMed ID: 1487461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prominent in situ component in a pleural malignant mesothelioma.
    Bono F; Lombardi M
    Int J Surg Pathol; 2015 Apr; 23(2):127-9. PubMed ID: 20643671
    [No Abstract]   [Full Text] [Related]  

  • 38. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Leu-M1, CEA and intermediate filament proteins in histochemical differential diagnosis of malignant pleural mesothelioma].
    Heckmayr M; Gatzmeier U; Schröder S; Niendorf A; Fasske E
    Pneumologie; 1990 Feb; 44 Suppl 1():618-9. PubMed ID: 2195531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of patterns of metastasis between malignant pleural mesotheliomas and pulmonary carcinomas].
    Scharmach M; Neumann V; Müller KM; Fischer M
    Pneumologie; 2006 May; 60(5):277-83. PubMed ID: 16703480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.